CIK 0000880242 · Non-accelerated filer<br>Smaller reporting company
BIOLARGO, INC.
Sign in to watch- Ticker
- BLGO
- Exchange
- OTC
- Industry
- Chemicals & Allied Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 650159115
- Phone
- 888 400-2863
- Business address
- 14921 CHESTNUT ST., WESTMINSTER, CA, 92683
- Former names
- NUWAY MEDICAL INC, NUWAY ENERGY INC, LATIN AMERICAN CASINOS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-31 | Runyan John S. Director | Grant or award · Option to Purchase Common Stock | +156,250 | 1,387,359 | ||
| 2018-12-31 | STROMMEN JACK B. Director | Grant or award · Option to Purchase Common Stock | +125,000 | 273,356 | ||
| 2018-09-30 | CODE KENNETH REAY Chief Science Officer | Grant or award | +130,187 | $0.27 | $35K | 22,603,858 |
| 2018-09-30 | Marshall Dennis E Director | Grant or award · Option to Purchase Common Stock | +69,444 | 2,309,411 | ||
| 2018-09-30 | Roberts Kent Charles II Director | Grant or award · Option to Purchase Common Stock | +55,556 | 1,179,445 | ||
| 2018-09-30 | Runyan John S. Director | Grant or award · Option to Purchase Common Stock | +69,444 | 1,231,109 | ||
| 2018-09-30 | STROMMEN JACK B. Director | Grant or award · Option to Purchase Common Stock | +55,556 | 148,356 | ||
| 2018-09-30 | CALVERT DENNIS P President | Grant or award | +119,071 | $0.27 | $32K | 8,505,625 |
| 2018-07-05 | CODE KENNETH REAY Chief Science Officer | Grant or award | +90,553 | $0.43 | $39K | 22,473,671 |
| 2018-07-05 | CALVERT DENNIS P President | Grant or award | +86,397 | $0.43 | $37K | 8,386,554 |
| 2018-06-29 | Runyan John S. Director | Grant or award · Option to Purchase Common Stock | +43,605 | 1,161,665 | ||
| 2018-06-29 | STROMMEN JACK B. Director | Conversion | +7,532 | $0.37 | $3K | 4,315,544 |
| 2018-06-29 | STROMMEN JACK B. Director | Grant or award · Option to Purchase Common Stock | +34,884 | 92,800 | ||
| 2018-06-29 | Roberts Kent Charles II Director | Grant or award · Option to Purchase Common Stock | +34,884 | 1,123,889 | ||
| 2018-06-29 | Runyan John S. Director | Grant or award · Option to Purchase Common Stock | +43,605 | 1,180,047 | ||
| 2018-06-29 | Marshall Dennis E Director | Grant or award · Option to Purchase Common Stock | +43,605 | 2,239,967 | ||
| 2018-05-18 | STROMMEN JACK B. Director | Conversion | +2,201,714 | $0.30 | $661K | 4,308,012 |
| 2018-05-18 | STROMMEN JACK B. Director | Conversion · Convertible Promissory Note | −0 | $0.30 | $0 | |
| 2018-05-02 | STROMMEN JACK B. Director | Conversion | +1,450,400 | $0.25 | $363K | 2,106,298 |
| 2018-05-02 | STROMMEN JACK B. Director | Conversion · Convertible Promissory Note | −0 | $0.25 | $0 |
Page 13 of 17 · 338 trades